Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Crystal structure of heliorhodopsin.
Shihoya W, Inoue K, Singh M, Konno M, Hososhima S, Yamashita K, Ikeda K, Higuchi A, Izume T, Okazaki S, Hashimoto M, Mizutori R, Tomida S, Yamauchi Y, Abe-Yoshizumi R, Katayama K, Tsunoda SP, Shibata M, Furutani Y, Pushkarev A, Béjà O, Uchihashi T, Kandori H, Nureki O. Shihoya W, et al. Among authors: hashimoto m. Nature. 2019 Oct;574(7776):132-136. doi: 10.1038/s41586-019-1604-6. Epub 2019 Sep 25. Nature. 2019. PMID: 31554965
Zinc Binding to Heliorhodopsin.
Hashimoto M, Katayama K, Furutani Y, Kandori H. Hashimoto M, et al. J Phys Chem Lett. 2020 Oct 15;11(20):8604-8609. doi: 10.1021/acs.jpclett.0c02383. Epub 2020 Sep 28. J Phys Chem Lett. 2020. PMID: 32940480
Specific zinc binding to heliorhodopsin.
Hashimoto M, Miyagawa K, Singh M, Katayama K, Shoji M, Furutani Y, Shigeta Y, Kandori H. Hashimoto M, et al. Phys Chem Chem Phys. 2023 Jan 27;25(4):3535-3543. doi: 10.1039/d2cp04718g. Phys Chem Chem Phys. 2023. PMID: 36637167
Internal Proton Transfer in the Activation of Heliorhodopsin.
Singh M, Hashimoto M, Katayama K, Furutani Y, Kandori H. Singh M, et al. Among authors: hashimoto m. J Mol Biol. 2024 Mar 1;436(5):168273. doi: 10.1016/j.jmb.2023.168273. Epub 2023 Sep 12. J Mol Biol. 2024. PMID: 37709010
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
Nakayama Y, Onishi A, Yamamoto W, Yoshikawa A, Shiba H, Yoshida N, Son Y, Shirasugi I, Maeda T, Katsushima M, Hashimoto M, Etani Y, Itami T, Nozaki Y, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Matsuda S, Morinobu A. Nakayama Y, et al. Among authors: hashimoto m. Clin Exp Med. 2024 May 10;24(1):97. doi: 10.1007/s10238-024-01360-w. Clin Exp Med. 2024. PMID: 38727756
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study.
Shiomi M, Watanabe R, Matsuda S, Kotani T, Okazaki A, Masuda Y, Yoshida T, Shoji M, Tsuge R, Kadoba K, Hiwa R, Yamamoto W, Takeda A, Itoh Y, Hashimoto M. Shiomi M, et al. Among authors: hashimoto m. Mod Rheumatol. 2024 May 10:roae044. doi: 10.1093/mr/roae044. Online ahead of print. Mod Rheumatol. 2024. PMID: 38727536
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K, Maeda Y, Jinno S, Shirasugi I, Son Y, Amuro H, Katayama M, Hara R, Hata K, Yoshikawa A, Yamamoto W, Tachibana S, Hayashi S, Etani Y, Katsushima M, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: hashimoto m. Rheumatology (Oxford). 2024 May 9:keae265. doi: 10.1093/rheumatology/keae265. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38724245
4,563 results